1. Dembele O. Risk-based post-marketing surveillance (RB-PMS2) of antimalarial and MNCH drugs in Mali (PY2). Int J Pharm Bio-Med Sci. 2022;2:09.
2. WHO. World malaria report 2020: 20 years of global progress and challenges. [Internet]. Geneva, World Health Organization, 2020. https://apps.who.int/iris/handle/10665/337660. (Accessed: 6 September 2022).
3. WHO. World malaria report 2022. . [Internet]. Geneva, World Health Organization, 2022. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report. [Accessed 29 May 2023].
4. Walker EJ, Peterson GM, Grech J, Paragalli E, Thomas J. Are we doing enough to prevent poor-quality antimalarial medicines in the developing world? BMC Public Health. 2018;18:630.
5. Al-Worafi YM. Counterfeit and substandard medications drug safety in `developing countries: achievements and challenges. London: Elsevier; 2020.